Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 91 AL 105

Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial

Reisberg B, Shao Y, Golomb J, Monteiro I, Torossian C, Boksay I, Shulman M, Heller S, Zhu Z, Atif A, Sidhu J, Vedvyas A, Kenowsky S.

Dement Geriatr Cogn Disord. 2017;43(1-2):100-117. doi: 10.1159/000455397. Epub 2017 Jan 26.

Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study

Li F, Chen S, Wei C, Jia J.

BMC Neurol. 2017 Jan 25;17(1):15. doi: 10.1186/s12883-017-0802-9.

Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review

Klimova B, Kuca K.

Curr Alzheimer Res. 2017;14(6):680-685. doi: 10.2174/1567205014666170117103656.

Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease

Giménez-Llort L, Ratia M, Pérez B, Camps P, Muñoz-Torrero D, Badia A, Clos MV.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):124-131. doi: 10.1097/FBP.0000000000000292.

Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?

Hunter S, Brayne C.

J Negat Results Biomed. 2017 Jan 26;16(1):1. doi: 10.1186/s12952-017-0066-3.

Alzheimer's disease: Innate immunity gone awry?

VanItallie TB.

Metabolism. 2017 Apr;69S:S41-S49. doi: 10.1016/j.metabol.2017.01.014. Epub 2017 Jan 11.

Very early-onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene

Lou F, Luo X, Li M, Ren Y, He Z.

Neurobiol Aging. 2017 May;53:193.e1-193.e5. doi: 10.1016/j.neurobiolaging.2016.12.026. Epub 2017 Jan 6.

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease

Wu WY, Dai YC, Li NG, Dong ZX, Gu T, Shi ZH, Xue X, Tang YP, Duan JA.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):572-587. doi: 10.1080/14756366.2016.1210139.

Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease

Sreenivasmurthy SG, Liu JY, Song JX, Yang CB, Malampati S, Wang ZY, Huang YY, Li M.

Int J Mol Sci. 2017 Jan 28;18(2):272. doi: 10.3390/ijms18020272.

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease

Chase TN, Farlow MR, Clarence-Smith K.

Neurotherapeutics. 2017 Apr;14(2):405-416. doi: 10.1007/s13311-016-0511-x.

Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview

Kumar A, Singh A, Aggarwal A.

Indian J Exp Biol. 2017 Feb;55(2):63-73.

Potential benefits of phytochemicals against Alzheimer's disease

Wightman EL.

Proc Nutr Soc. 2017 May;76(2):106-112. doi: 10.1017/S0029665116002962. Epub 2017 Feb 1.

microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease

Salta E, De Strooper B.

FASEB J. 2017 Feb;31(2):424-433. doi: 10.1096/fj.201601308.

A capillary electrophoresis-mass spectrometry based method for the screening of β-secretase inhibitors as potential Alzheimer's disease therapeutics

Schejbal J, Slezáčková L, Řemínek R, Glatz Z.

J Chromatogr A. 2017 Mar 3;1487:235-241. doi: 10.1016/j.chroma.2017.01.057. Epub 2017 Jan 23.

Exploration of Various Proteins for the Treatment of Alzheimer's Disease

Islam BU, Zaidi SK, Kamal MA, Tabrez S.

Curr Drug Metab. 2017;18(9):808-813. doi: 10.2174/1389200218666170203110135.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias